Ulrich Döres

Part of Taunus Capital Management AG, blue-zone AG is a German cleantech pharmaceutical company that operates a fully operational, GMP compliant, Health Canada licensed drug establishment facility for anesthetic recovery, raw material, and final product production. The company is based in Rosenheim, Germany. The company's mission is to reduce hospital's hazardous environmental waste and lower financial costs by applying blue-zone's patented technology. Blue-zone collects unused anesthetics that would normally be vented into the environment and processes the collected material into its pure form, providing a sustainable and cost-efficient source of inhalation anesthetic drugs. The company was founded in 2011. Blue-zone AG was acquired by All for One Group SE on December 02, 2021.